Didier Landais
Chief Executive Officer at 4P-Pharma
Profile
Didier Landais is the Chief Executive Officer at 4P-Pharma since 2023.
Prior to this, he worked as a Project Leader at Rhone Poulenc AG, Inc., Vice President & Head-Development at Biotecnol-Serviços e Desenvolvimento SA, and Chief Operating & Business Officer at LabGenius Ltd.
Dr. Landais holds an MBA from ESSEC Business School and undergraduate, graduate, and doctorate degrees from the University of Strasbourg.
Didier Landais active positions
Companies | Position | Start |
---|---|---|
4P-Pharma | Chief Executive Officer | 2023-08-31 |
Former positions of Didier Landais
Companies | Position | End |
---|---|---|
Rhone Poulenc AG, Inc. | Corporate Officer/Principal | - |
Labgenius Ltd.
Labgenius Ltd. Pharmaceuticals: MajorHealth Technology Labgenius Ltd. discovers novel and optimized biological molecules using artificial intelligence, automation and synthetic DNA. It specializes in synthetic biology, DNA libraries, protein engineering, artificial intelligence and machine learning. The company was founded by James Field in 2012 and is headquartered in London, the United Kingdom. | Chief Operating Officer | - |
Biotecnol-Serviços e Desenvolvimento SA
Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal. | Corporate Officer/Principal | - |
Training of Didier Landais
University of Strasbourg | Doctorate Degree |
ESSEC Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Biotecnol-Serviços e Desenvolvimento SA
Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal. | Commercial Services |
Rhone Poulenc AG, Inc. | Process Industries |
Labgenius Ltd.
Labgenius Ltd. Pharmaceuticals: MajorHealth Technology Labgenius Ltd. discovers novel and optimized biological molecules using artificial intelligence, automation and synthetic DNA. It specializes in synthetic biology, DNA libraries, protein engineering, artificial intelligence and machine learning. The company was founded by James Field in 2012 and is headquartered in London, the United Kingdom. | Health Technology |
4P-Pharma | Commercial Services |
- Stock Market
- Insiders
- Didier Landais